Perseus Proteomics Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Perseus Proteomics Inc. made a loss over the last year. Perseus Proteomics Inc. owes ¥0.27 for every ¥1 it owns. Perseus Proteomics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossPerseus Proteomics Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.06The share price is 2.06 times Perseus Proteomics Inc.'s book value per share, higher than 65% of Healthcare companies in Japan.
Market cap
¥2.5 BThe total market value of all of Perseus Proteomics Inc.'s shares at today's price (share price × number of shares), smaller than 92% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.2 BWhat Perseus Proteomics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥66.35Net worth divided by the number of shares. The share price of ¥137.00 is 2.1 times this, which is the P/B above.
Return on equity (ROE)
-60.1%Perseus Proteomics Inc. lost 60.1% of its shareholders' money over the last year, lower than 90% of Healthcare companies in Japan.
Owes vs Owns
0.27×Perseus Proteomics Inc. owes ¥0.27 for every ¥1 it owns (low), lower than 66% of Healthcare companies in Japan.
Dividend yield
NonePerseus Proteomics Inc. does not currently pay a dividend.
Revenue growth
+13%Revenue rose 13% in the year to Mar 2026, and grew 13% a year on average over 3 years.
Profit growth
LossPerseus Proteomics Inc. made a loss in each of the last two years.
Profit margin
-529.9%Perseus Proteomics Inc. lost ¥530 for every ¥100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Perseus Proteomics Inc.: ¥2.5 B ÷ ¥1.2 B (30 Jun 2026) = 2.1.
What is Perseus Proteomics Inc.'s return on equity?
Perseus Proteomics Inc. lost 60.1% of its shareholders' money over the last year, lower than 90% of Healthcare companies in Japan.
How much does Perseus Proteomics Inc. owe compared with what it owns?
Perseus Proteomics Inc. owes ¥0.27 for every ¥1 it owns (low), lower than 66% of Healthcare companies in Japan.
Does Perseus Proteomics Inc. pay a dividend?
No. Perseus Proteomics Inc. does not currently pay a dividend.
Is Perseus Proteomics Inc.'s revenue growing?
Revenue rose 13% in the year to Mar 2026, and grew 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.